EDAP TMS SA Announces Upcoming Presentation at Key Healthcare Event
EDAP TMS SA Engages Investors at Piper Sandler Healthcare Conference
EDAP TMS SA (Nasdaq: EDAP), a prominent name in robotic energy-based therapies, recently announced its participation in the prestigious Piper Sandler 37th Annual Healthcare Conference. This event will take place in New York City, bringing together industry leaders and investors to discuss advancements in healthcare.
Details of the Conference Presentation
Chief Executive Officer Ryan Rhodes will represent the company, alongside Chief Financial Officer Ken Mobeck, to share valuable insights and developments from EDAP. The presentation is scheduled for Tuesday, December 2, and includes a unique opportunity for one-on-one meetings with investors.
During the fireside discussion, which begins at 10:30 AM ET, Rhodes and Mobeck will delve into the latest innovations in robotic therapies and the company’s strategic vision for the future. This forum aims to foster deeper relationships with stakeholders while enhancing transparency regarding the company's initiatives.
Accessing the Live Webcast
For those unable to attend in person, EDAP will provide a live and archived webcast of the presentation, ensuring that all interested parties can access critical updates. Investors can find the webcast portal in the Investors section of the company's official website.
About EDAP TMS SA
EDAP TMS is recognized as a leader in minimally invasive medical technologies. By leveraging advanced ultrasound technology, the company develops, manufactures, and distributes innovative equipment aimed at treating various medical conditions. Among its key innovations is the Focal One system, a controlled focal therapy for prostate issues, which positions EDAP as a pioneer in non-invasive treatment options.
Future of Robotic Therapies
With a commitment to continuous improvement and innovation, EDAP is exploring potential expansions beyond prostate cancer therapies. Their robotic solutions offer enhanced precision and patient comfort, setting new standards in the medical field.
Investor Communication and Queries
EDAP TMS remains dedicated to effective communication with its investors. For inquiries, parties can reach out through established channels listed on their website.
Frequently Asked Questions
What is the focus of EDAP's presentation at the Piper Sandler Conference?
The presentation will cover the latest advancements in robotic energy-based therapies and the company's future strategies.
When will EDAP's presentation take place during the conference?
The presentation is scheduled for Tuesday, December 2, at 10:30 AM ET.
How can investors access the presentation if they cannot attend?
Investors can access the live and archived webcast of the presentation on the Investors section of EDAP's website.
What innovative products does EDAP offer?
EDAP develops the Focal One system, which provides a minimally invasive solution for prostate therapies using advanced ultrasound technology.
How can investors contact EDAP for inquiries?
Investors can reach EDAP's Investor Relations via email at investor.relations@focalone.com.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.